{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:39:50Z","timestamp":1773855590604,"version":"3.50.1"},"publisher-location":"Cham","reference-count":115,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031970542","type":"print"},{"value":"9783031970559","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-97055-9_4","type":"book-chapter","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T05:07:42Z","timestamp":1758863262000},"page":"65-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prion Disease Diagnostic Biomarker Utility in Pre-symptomatic Disease"],"prefix":"10.1007","author":[{"given":"Laura J.","family":"Ellett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Senesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.648743","volume":"15","author":"S Abu-Rumeileh","year":"2021","unstructured":"Abu-Rumeileh S, Parchi P (2021) Cerebrospinal fluid and blood neurofilament light chain protein in Prion disease and other rapidly progressive dementias: current state of the art. Front Neurosci 15:648743","journal-title":"Front Neurosci"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41591-024-03466-w","volume":"31","author":"M An","year":"2025","unstructured":"An M, Davis JR, Levy JM, Serack FE, Harvey JW, Brauer PP, Pirtle CP, Berr\u00edos KN, Newby GA, Yeh W-H, Kamath N, Mortberg MA, Lian Y, Howard MJ, DeSouza-Lenz K, Guzman K, Thai A, Graffam S, Laversenne V, Coffey AA, Frei J, Pierce SE, Safar JG, Deverman BE, Minikel EV, Vallabh SM, Liu DR (2025) In vivo base editing extends lifespan of a humanized mouse model of prion disease. Nat Med 31:1319","journal-title":"Nat Med"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3233\/JAD-132465","volume":"42","author":"BS Appleby","year":"2014","unstructured":"Appleby BS, Rincon-Beardsley TD, Appleby KK, Crain BJ, Wallin MT (2014) Initial diagnoses of patients ultimately diagnosed with prion disease. J Alzheimers Dis 42:833\u2013839","journal-title":"J Alzheimers Dis"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"1003056","DOI":"10.3389\/fneur.2022.1003056","volume":"13","author":"BS Appleby","year":"2022","unstructured":"Appleby BS, Shetty S, Elkasaby M (2022) Genetic aspects of human prion diseases. Front Neurol 13:1003056","journal-title":"Front Neurol"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamanaka H, Shirabe S, Yamada M, Mizusawa H, Kitamoto T, Klug G, McGlade A, Collins SJ, Nishida N (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17:175\u2013178","journal-title":"Nat Med"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00401-021-02350-y","volume":"142","author":"S Baiardi","year":"2021","unstructured":"Baiardi S, Rossi M, Mammana A, Appleby BS, Barria MA, Cali I, Gambetti P, Gelpi E, Giese A, Ghetti B, Herms J, Ladogana A, Mikol J, Pal S, Ritchie DL, Ruf V, Windl O, Capellari S, Parchi P (2021) Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classification. Acta Neuropathol 142:707\u2013728","journal-title":"Acta Neuropathol"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1126\/science.1215659","volume":"335","author":"V Beringue","year":"2012","unstructured":"Beringue V, Herzog L, Jaumain E, Reine F, Sibille P, Le Dur A, Vilotte JL, Laude H (2012) Facilitated cross-species transmission of prions in extraneural tissue. Science 335:472\u2013475","journal-title":"Science"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamaneurol.2020.1319","volume":"77","author":"A Bizzi","year":"2020","unstructured":"Bizzi A, Pascuzzo R, Blevins J, Grisoli M, Lodi R, Moscatelli MEM, Castelli G, Cohen ML, Schonberger LB, Foutz A, Safar JG, Appleby BS, Gambetti P (2020) Evaluation of a new criterion for detecting Prion disease with diffusion magnetic resonance imaging. JAMA Neurol 77:1141\u20131149","journal-title":"JAMA Neurol"},{"key":"4_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8974","volume":"12","author":"G Boero","year":"2024","unstructured":"Boero G, Lauriero F, Fusillo D, Calvello R, Cianciulli A, Panaro MA, Moda P (2024) 18F-FDG PET\/CT in early phase of sporadic Creutzfeldt-Jacob disease: a case report. Clin Case Reports 12:e8974","journal-title":"Clin Case Reports"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"370ra182","DOI":"10.1126\/scitranslmed.aag1257","volume":"8","author":"D Bougard","year":"2016","unstructured":"Bougard D, Brandel JP, B\u00e9londrade M, B\u00e9ringue V, Segarra C, Fleury H, Laplanche JL, Mayran C, Nicot S, Green A, Welaratne A, Narbey D, Fournier-Wirth C, Knight R, Will R, Tiberghien P, Ha\u00efk S, Coste J (2016) Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease. Sci Transl Med 8:370ra182","journal-title":"Sci Transl Med"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.brainresbull.2005.09.010","volume":"68","author":"MW Brazier","year":"2006","unstructured":"Brazier MW, Lewis V, Ciccotosto GD, Klug GM, Lawson VA, Cappai R, Ironside JW, Masters CL, Hill AF, White AR, Collins S (2006) Correlative studies support lipid peroxidation is linked to PrPres propagation as an early primary pathogenic event in prion disease. Brain Res Bull 68:346\u2013354","journal-title":"Brain Res Bull"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","volume":"73","author":"H B\u00fceler","year":"1993","unstructured":"B\u00fceler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339\u20131347","journal-title":"Cell"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3389\/fnins.2019.00934","volume":"13","author":"C Chen","year":"2019","unstructured":"Chen C, Hu C, Shi Q, Zhou W, Mao K, Wang Y, Liu L, Chen J, Xia Y, Dong XP (2019) Profiles of 14-3-3 and Total Tau in CSF samples of Chinese patients of different genetic Prion diseases. Front Neurosci 13:934\u2013934","journal-title":"Front Neurosci"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1016\/j.nbd.2024.106497","volume":"195","author":"ZY Chen","year":"2024","unstructured":"Chen ZY, Kong Y, Zhang J, Zou WQ, Wu LY (2024) Genetic and pathological features encipher the phenotypic heterogeneity of Gerstmann-Straussler-Scheinker disease. Neurobiol Dis 195:6497\u20136497","journal-title":"Neurobiol Dis"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/jnnp.2009.197962","volume":"81","author":"G Chohan","year":"2010","unstructured":"Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RSG, Green AJE (2010) The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 81:1243\u20131248","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.1007\/s00415-022-11288-4","volume":"269","author":"M Chu","year":"2022","unstructured":"Chu M, Chen ZY, Nie BB, Liu L, Xie KX, Cui Y, Chen KW, Rosa-Neto P, Wu LY (2022) A longitudinal F-18-FDG PET\/MRI study in asymptomatic stage of genetic Creutzfeldt-Jakob disease linked to G114V mutation. J Neurol 269:6094\u20136103","journal-title":"J Neurol"},{"key":"4_CR17","unstructured":"CJD Diagnostic Criteria (2024) U.S. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/creutzfeldt-jakob\/hcp\/clinical-overview\/diagnosis.html"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00415-014-7615-1","volume":"262","author":"OS Cohen","year":"2015","unstructured":"Cohen OS, Chapman J, Korczyn AD, Nitsan Z, Appel S, Hoffmann C, Rosenmann H, Kahana E, Lee H (2015) Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD. J Neurol 262:604\u2013613","journal-title":"J Neurol"},{"key":"4_CR19","first-page":"1560","volume":"24","author":"DA Collie","year":"2003","unstructured":"Collie DA, Summers DM, Sellar RJ, Ironside JW, Cooper S, Zeidler M, Knight R, Will RG (2003) Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 24:1560\u20131569","journal-title":"AJNR Am J Neuroradiol"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/383685a0","volume":"383","author":"J Collinge","year":"1996","unstructured":"Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383:685\u2013690","journal-title":"Nature"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1054\/jocn.2001.0919","volume":"8","author":"S Collins","year":"2001","unstructured":"Collins S, McLean CA, Masters CL (2001) Gerstmann-Str\u00e4ussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci 8:387\u2013397","journal-title":"J Clin Neurosci"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/brain\/awl159","volume":"129","author":"SJ Collins","year":"2006","unstructured":"Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemann U, Kretszchmar HA, Jansen GH, Olsen E, Mitrova E, Alperovitch A, Brandel JP, Mackenzie J, Murray K, Will RG (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 129:2278\u20132287","journal-title":"Brain"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"370ra183","DOI":"10.1126\/scitranslmed.aaf6188","volume":"8","author":"L Concha-Marambio","year":"2016","unstructured":"Concha-Marambio L, Pritzkow S, Moda F, Tagliavini F, Ironside JW, Schulz PE, Soto C (2016) Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease. Sci Transl Med 8:370ra183","journal-title":"Sci Transl Med"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/brain\/awl003","volume":"129","author":"P Cortelli","year":"2006","unstructured":"Cortelli P, Perani D, Montagna P, Gallassi R, Tinuper P, Federica P, Avoni P, Ferrillo F, Anchisi D, Moresco RM, Fazio F, Parchi P, Baruzzi A, Lugaresi E, Gambetti P (2006) Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies. Brain 129:668\u2013675","journal-title":"Brain"},{"key":"4_CR25","volume-title":"Handbook of clinical neurology","author":"L Cracco","year":"2018","unstructured":"Cracco L, Appleby BS, Gambetti P (2018) Chapter 15 - fatal familial insomnia and sporadic fatal insomnia. In: Pocchiari M, Manson J (eds) Handbook of clinical neurology. Elsevier, Amsterdam, Netherlands"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12035-014-8709-6","volume":"51","author":"M Cramm","year":"2015","unstructured":"Cramm M, Schmitz M, Karch A, Zafar S, Varges D, Mitrova E, Schroeder B, Raeber A, Kuhn F, Zerr I (2015) Characteristic CSF prion seeding efficiency in humans with prion diseases. Mol Neurobiol 51:396\u2013405","journal-title":"Mol Neurobiol"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","volume":"53","author":"M Cramm","year":"2016","unstructured":"Cramm M, Schmitz M, Karch A, Mitrova E, Kuhn F, Schroeder B, Raeber A, Varges D, Kim YS, Satoh K, Collins S, Zerr I (2016) Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol 53:1896\u20131904","journal-title":"Mol Neurobiol"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1046\/j.1460-9568.2003.02662.x","volume":"17","author":"C Cunningham","year":"2003","unstructured":"Cunningham C, Deacon R, Wells H, Boche D, Waters S, Diniz CP, Scott H, Rawlins JNP, Perry VH (2003) Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci 17:2147\u20132155","journal-title":"Eur J Neurosci"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.nbd.2004.08.015","volume":"18","author":"C Cunningham","year":"2005","unstructured":"Cunningham C, Deacon RMJ, Chan K, Boche D, Rawlins JNP, Perry VH (2005) Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits. Neurobiol Dis 18:258\u2013269","journal-title":"Neurobiol Dis"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3201\/eid3010.240159","volume":"30","author":"ND Denkers","year":"2024","unstructured":"Denkers ND, McNulty EE, Kraft CN, Nalls AV, Westrich JA, Hoover EA, Mathiason CK (2024) Temporal characterization of Prion shedding in Secreta of White-tailed deer in longitudinal study of Chronic Wasting disease, United States. Emerg Infect Dis 30:2118\u20132127","journal-title":"Emerg Infect Dis"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/pathogens10030305","volume":"10","author":"TT Dong","year":"2021","unstructured":"Dong TT, Satoh K (2021) The latest research on RT-QuIC assays-a literature review. Pathogens 10:305","journal-title":"Pathogens"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"10655","DOI":"10.1038\/s41598-017-10922-w","volume":"7","author":"A Franceschini","year":"2017","unstructured":"Franceschini A, Baiardi S, Hughson AG, McKenzie N, Moda F, Rossi M, Capellari S, Green A, Giaccone G, Caughey B, Parchi P (2017) High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions. Sci Rep 7:10655\u201310655","journal-title":"Sci Rep"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"1411489","DOI":"10.3389\/fpubh.2024.1411489","volume":"12","author":"LP Gao","year":"2024","unstructured":"Gao LP, Tian TT, Xiao K, Chen C, Zhou W, Liang DL, Cao RD, Shi Q, Dong XP (2024) Updated global epidemiology atlas of human prion diseases. Front Public Health 12:1411489","journal-title":"Front Public Health"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/35020688","volume":"406","author":"AC Ghani","year":"2000","unstructured":"Ghani AC, Ferguson NM, Donnelly CA, Anderson RM (2000) Predicted vCJD mortality in Great Britain. Nature 406:583\u2013584","journal-title":"Nature"},{"key":"4_CR35","volume-title":"Handbook of clinical neurology","author":"B Ghetti","year":"2018","unstructured":"Ghetti B, Piccardo P, Zanusso G (2018) Chapter 14 - Dominantly inherited prion protein cerebral amyloidoses\u2014a modern view of Gerstmann\u2013Str\u00e4ussler\u2013Scheinker. In: Pocchiari M, Manson J (eds) Handbook of clinical neurology. Elsevier, Amsterdam, Netherlands"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/WAD.0000000000000049","volume":"29","author":"N Ghoshal","year":"2015","unstructured":"Ghoshal N, Perry A, McKeel D, Schmidt RE, Carter D, Norton J, Zou WQ, Xiao XZ, Puoti G, Notari S, Gambetti P, Morris JC, Cairns NJ (2015) Variably protease-sensitive prionopathy in an apparent cognitively normal 93-year-old. Alzheimer Dis Assoc Disord 29:173\u2013176","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"4_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5675","volume":"347","author":"ON Gill","year":"2013","unstructured":"Gill ON, Spencer Y, Richard-Loendt A, Kelly C, Dabaghian R, Boyes L, Linehan J, Simmons M, Webb P, Bellerby P, Andrews N, Hilton DA, Ironside JW, Beck J, Poulter M, Mead S, Brandner S (2013) Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 347:f5675","journal-title":"BMJ"},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3233\/JAD-160750","volume":"55","author":"O Grau-Rivera","year":"2016","unstructured":"Grau-Rivera O, Calvo A, Bargallo N, Monte GC, Nos C, Llado A, Molinuevo JL, Gelpi E, Sanchez-Valle R (2016) Quantitative magnetic resonance abnormalities in Creutzfeldt-Jakob disease and fatal insomnia. J Alzheimers Dis 55:431\u2013443","journal-title":"J Alzheimers Dis"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/practneurol-2018-001935","volume":"19","author":"AJE Green","year":"2019","unstructured":"Green AJE (2019) RT-QuIC: a new test for sporadic CJD. Pract Neurol 19:49\u201355","journal-title":"Pract Neurol"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.2169\/internalmedicine.8354-21","volume":"61","author":"Y Hamada","year":"2022","unstructured":"Hamada Y, Deguchi K, Tachi K, Kita M, Nonaka W, Takata T, Kobara H, Touge T, Satoh K, Masaki T (2022) Significance of cortical ribboning as a biomarker in the prodromal phase of sporadic Creutzfeldt-Jakob disease. Intern Med 61:2667\u20132670","journal-title":"Intern Med"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"E331","DOI":"10.1212\/WNL.0000000000005860","volume":"91","author":"P Hermann","year":"2018","unstructured":"Hermann P, Laux M, Glatzel M, Matschke J, Knipper T, Goebel S, Treig J, Schulz-Schaeffer W, Cramm M, Schmitz M, Zerr I (2018) Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology 91:E331\u2013EE38","journal-title":"Neurology"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00115-024-01644-2","volume":"95","author":"P Hermann","year":"2024","unstructured":"Hermann P, Goebel S, Zerr I (2024) Clinical characteristics and diagnostics of human spongiform encephalopathies: an update. Nervenarzt 95:376\u2013384","journal-title":"Nervenarzt"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/path.1580","volume":"203","author":"DA Hilton","year":"2004","unstructured":"Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, Penney M, Hegazy D, Ironside JW (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203:733\u2013739","journal-title":"J Pathol"},{"key":"4_CR44","unstructured":"Ionis Pharmaceuticals, Inc (2024) PrProfile: a study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ION717, ClinicalTrials.gov, Accessed 10\/4\/2025. https:\/\/clinicaltrials.gov\/study\/NCT06153966?cond=prion&rank=2"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/neup.12327","volume":"37","author":"Y Iwasaki","year":"2017","unstructured":"Iwasaki Y, Mori K, Ito M, Mimuro M, Kitamoto T, Yoshida M (2017) An autopsied case of MM1 + MM2-cortical with thalamic-type sporadic Creutzfeldt-Jakob disease presenting with hyperintensities on diffusion-weighted MRI before clinical onset. Neuropathology 37:78\u201385","journal-title":"Neuropathology"},{"key":"4_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.751750","volume":"12","author":"R Koizumi","year":"2021","unstructured":"Koizumi R, Ueda N, Mugita A, Kimura K, Kishida H, Tanaka F (2021) Case report: extremely early detection of preclinical magnetic resonance imaging abnormality in Creutzfeldt-Jakob disease with the V180I mutation. Front Neurol 12:751750","journal-title":"Front Neurol"},{"key":"4_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106805","volume":"206","author":"Y Kong","year":"2025","unstructured":"Kong Y, Chen Z, Zhang J, Wang Y, Chu M, Nan H, Cui Y, Jiang D, Liyong W (2025) Reconfigured metabolism brain network in asymptomatic Creutzfeldt-Jakob disease. Neurobiol Dis 206:106805","journal-title":"Neurobiol Dis"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","volume":"118","author":"GG Kov\u00e1cs","year":"2005","unstructured":"Kov\u00e1cs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar HA, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166\u2013174","journal-title":"Hum Genet"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1099\/jgv.0.001825","volume":"104","author":"CN Kraft","year":"2023","unstructured":"Kraft CN, Denkers ND, Mathiason CK, Hoover EA (2023) Longitudinal detection of prion shedding in nasal secretions of CWD-infected white-tailed deer. J Gen Virol 104:1825\u20131825","journal-title":"J Gen Virol"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00415-014-7410-z","volume":"261","author":"A Krasnianski","year":"2014","unstructured":"Krasnianski A, Kaune J, Jung K, Kretzschmar HA, Zerr I (2014) First symptom and initial diagnosis in sporadic CJD patients in Germany. J Neurol 261:1811\u20131817","journal-title":"J Neurol"},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/WNO.0000000000000185","volume":"35","author":"KM Kulkarni","year":"2015","unstructured":"Kulkarni KM (2015) Progressive MRI findings in Creutzfeldt-Jakob disease. J Neuroophthalmol 35:96\u201398","journal-title":"J Neuroophthalmol"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/B978-0-444-63945-5.00013-1","volume":"153","author":"A Ladogana","year":"2018","unstructured":"Ladogana A, Kovacs GG (2018) Genetic Creutzfeldt-Jakob disease. Handb Clin Neurol 153:219\u2013242","journal-title":"Handb Clin Neurol"},{"key":"4_CR53","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1007\/s00415-009-5163-x","volume":"256","author":"A Ladogana","year":"2009","unstructured":"Ladogana A, Sanchez-Juan P, Mitrova E, Green A, Cuadrado-Corrales N, Sanchez-Valle R, Koscova S, Aguzzi A, Sklaviadis T, Kulczycki J, Gawinecka J, Saiz A, Calero M, van Duijn CM, Pocchiari M, Knight R, Zerr I (2009) Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol 256:1620\u20131628","journal-title":"J Neurol"},{"key":"4_CR54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00401-017-1683-0","volume":"133","author":"F Lattanzio","year":"2017","unstructured":"Lattanzio F, Abu-Rumeileh S, Franceschini A, Kai H, Amore G, Poggiolini I, Rossi M, Baiardi S, McGuire L, Ladogana A, Pocchiari M, Green A, Capellari S, Parchi P (2017) Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A\u03b242 levels. Acta Neuropathol 133:559\u2013578","journal-title":"Acta Neuropathol"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-200576","volume":"77","author":"H Lu","year":"2020","unstructured":"Lu H, Jing D, Chen Y, Cui C, Gao R, Wang L, Liang Z, Chen K, Wu L (2020) Metabolic changes detected by 18F-FDG PET in the preclinical stage of familial Creutzfeldt-Jakob disease. J Alzheimers Dis 77:1\u20139","journal-title":"J Alzheimers Dis"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2169\/internalmedicine.1155-18","volume":"58","author":"K Maeda","year":"2019","unstructured":"Maeda K, Sugihara Y, Shiraishi T, Hirai A, Satoh K (2019) Cortical Hyperintensity on diffusion-weighted images as the presymptomatic marker of Sporadic Creutzfeldt-Jakob disease. Intern Med 58:727\u2013729","journal-title":"Intern Med"},{"key":"4_CR57","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1126\/science.1090187","volume":"302","author":"G Mallucci","year":"2003","unstructured":"Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302:871\u2013874","journal-title":"Science"},{"key":"4_CR58","unstructured":"Masters CL, Kakulas BA, Alpers MP, Gajdusek DC, Gibbs CJ Jr (1975) Preclinical lesions and their progression in the experimental spongiform encephalopathies (kuru and Creutzfeldt-Jakob disease) in primates. In: Tariska YS, Gosztonyi G (eds) Proceedings of the seventh international congress of neuropathology. Excerpta Medica, Amsterdam, Netherlands; Budapest, Hungary, pp 23\u201326"},{"key":"4_CR59","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00005072-198405000-00003","volume":"43","author":"CL Masters","year":"1984","unstructured":"Masters CL, Rohwer RG, Franko MC, Brown P, Gajdusek DC (1984) The sequential development of spongiform change and gliosis of scrapie in the golden Syrian hamster. J Neuropathol Exp Neurol 43:242\u2013252","journal-title":"J Neuropathol Exp Neurol"},{"key":"4_CR60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11307-024-01895-0","volume":"26","author":"MV Mattoli","year":"2024","unstructured":"Mattoli MV, Giancipoli RG, Cocciolillo F, Calcagni ML, Taralli S (2024) The role of PET imaging in patients with Prion disease: a literature review. Mol Imaging Biol 26:195","journal-title":"Mol Imaging Biol"},{"key":"4_CR61","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1212\/WNL.49.2.552","volume":"49","author":"CA McLean","year":"1997","unstructured":"McLean CA, Storey E, Gardner RJ, Tannenberg AE, Cervenakova L, Brown P (1997) The D178N (cis-129M) \"fatal familial insomnia\" mutation associated with diverse clinicopathologic phenotypes in an Australian kindred. Neurology 49:552\u2013558","journal-title":"Neurology"},{"key":"4_CR62","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/brain\/awl226","volume":"129","author":"S Mead","year":"2006","unstructured":"Mead S, Poulter M, Beck J, Webb TE, Campbell TA, Linehan JM, Desbruslais M, Joiner S, Wadsworth JD, King A, Lantos P, Collinge J (2006) Inherited prion disease with six octapeptide repeat insertional mutation\u2014molecular analysis of phenotypic heterogeneity. Brain 129:2297\u20132317","journal-title":"Brain"},{"key":"4_CR63","doi-asserted-by":"publisher","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","volume":"8","author":"EV Minikel","year":"2016","unstructured":"Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LP, Gambetti P, Blevins J, Zhang S, Cohen Y, Chen W, Yamada M, Hamaguchi T, Sanjo N, Mizusawa H, Nakamura Y, Kitamoto T, Collins SJ, Boyd A, Will RG, Knight R, Ponto C, Zerr I, Kraus TF, Eigenbrod S, Giese A, Calero M, de Pedro-Cuesta J, Haik S, Laplanche JL, Bouaziz-Amar E, Brandel JP, Capellari S, Parchi P, Poleggi A, Ladogana A, O'Donnell-Luria AH, Karczewski KJ, Marshall JL, Boehnke M, Laakso M, Mohlke KL, Kahler A, Chambert K, McCarroll S, Sullivan PF, Hultman CM, Purcell SM, Sklar P, van der Lee SJ, Rozemuller A, Jansen C, Hofman A, Kraaij R, van Rooij JG, Ikram MA, Uitterlinden AG, van Duijn CM, Consortium Exome Aggregation, Daly MJ, MacArthur DG (2016) Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med 8:322ra9","journal-title":"Sci Transl Med"},{"key":"4_CR64","doi-asserted-by":"publisher","first-page":"E125","DOI":"10.1212\/WNL.0000000000007745","volume":"93","author":"EV Minikel","year":"2019","unstructured":"Minikel EV, Vallabh SM, Orseth MC, Brandel JP, Haik S, Laplanche JL, Zerr I, Parchi P, Capellari S, Safar J, Kenny J, Fong JC, Takada LT, Ponto C, Hermann P, Knipper T, Stehmann C, Kitamoto T, Ae R, Hamaguchi T, Sanjo N, Tsukamoto T, Mizusawa H, Collins SJ, Chiesa R, Roiter I, de Pedro-Cuesta J, Calero M, Geschwind MD, Yamada M, Nakamura Y, Mead S (2019) Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology 93:E125\u2013EE34","journal-title":"Neurology"},{"key":"4_CR65","doi-asserted-by":"publisher","first-page":"10615","DOI":"10.1093\/nar\/gkaa616","volume":"48","author":"EV Minikel","year":"2020","unstructured":"Minikel EV, Zhao HT, Le J, O'Moore J, Pitstick R, Graffam S, Carlson GA, Kavanaugh MP, Kriz J, Kim JB, Ma JY, Wille H, Aiken J, McKenzie D, Doh-Ura K, Beck M, O'Keefe R, Stathopoulos J, Caron T, Schreiber SL, Carroll JB, Kordasiewicz HB, Cabin DE, Vallabh SM (2020) Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints. Nucleic Acids Res 48:10615\u201310631","journal-title":"Nucleic Acids Res"},{"key":"4_CR66","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJMc1610003","volume":"376","author":"T Mok","year":"2017","unstructured":"Mok T, Jaunmuktane Z, Joiner S, Campbell T, Morgan C, Wakerley B, Golestani F, Rudge P, Mead S, Jager HR, Wadsworth JDF, Brandner S, Collinge J (2017) Variant Creutzfeldt-Jakob disease in a patient with heterozygosity at PRNP Codon 129. N Engl J Med 376:292\u2013294","journal-title":"N Engl J Med"},{"key":"4_CR67","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1038\/s41598-021-84527-9","volume":"11","author":"TH Mok","year":"2021","unstructured":"Mok TH, Nihat A, Luk C, Sequeira D, Batchelor M, Mead S, Collinge J, Jackson GS (2021) Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases. Sci Rep 11:5231\u20135231","journal-title":"Sci Rep"},{"key":"4_CR68","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1093\/brain\/awad101","volume":"146","author":"TH Mok","year":"2023","unstructured":"Mok TH, Nihat A, Majbour N, Sequeira D, Holm-Mercer L, Coysh T, Darwent L, Batchelor M, Groveman BR, Orr CD, Hughson AG, Heslegrave A, Laban R, Veleva E, Paterson RW, Keshavan A, Schott JM, Swift IJ, Heller C, Rohrer JD, Gerhard A, Butler C, Rowe JB, Masellis M, Chapman M, Lunn MP, Bieschke J, Jackson GS, Zetterberg H, Caughey B, Rudge P, Collinge J, Mead S (2023) Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease. Brain 146:2570\u20132583","journal-title":"Brain"},{"key":"4_CR69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(03)00323-5","volume":"2","author":"P Montagna","year":"2003","unstructured":"Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003) Familial and sporadic fatal insomnia. Lancet Neurol 2:167\u2013176","journal-title":"Lancet Neurol"},{"key":"4_CR70","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.0b013e31826d5fc3","volume":"79","author":"T Muayqil","year":"2012","unstructured":"Muayqil T, Gronseth G, Camicioli R (2012) Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 79:1499\u20131506","journal-title":"Neurology"},{"key":"4_CR71","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMc2204116","volume":"386","author":"T Nakagaki","year":"2022","unstructured":"Nakagaki T, Kaneko M, Satoh K, Murai K, Saiki K, Matsumoto G, Ogami-Takamura K, Ikematsu K, Akagi A, Iwasaki Y, Tsurumoto T, Nishida N (2022) Detection of Prions in a Cadaver for anatomical practice. N Engl J Med 386:2245\u20132246","journal-title":"N Engl J Med"},{"key":"4_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2011.6","volume":"1","author":"K Nazor Friberg","year":"2012","unstructured":"Nazor Friberg K, Hung G, Wancewicz E, Giles K, Black C, Freier S, Bennett F, Dearmond SJ, Freyman Y, Lessard P, Ghaemmaghami S, Prusiner SB (2012) Intracerebral infusion of antisense Oligonucleotides into Prion-infected mice. Mol Ther Nucleic Acids 1:e9","journal-title":"Mol Ther Nucleic Acids"},{"key":"4_CR73","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1212\/WNL.38.7.1133","volume":"38","author":"MI New","year":"1988","unstructured":"New MI, Brown P, Temeck JW, Owens C, Hedly-Whyte ET, Richardson EP (1988) Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient. Neurology 38:1133\u20131134","journal-title":"Neurology"},{"key":"4_CR74","doi-asserted-by":"publisher","first-page":"E127","DOI":"10.1111\/ene.13807","volume":"25","author":"G Novi","year":"2018","unstructured":"Novi G, Canosa A, Nobili F, Bongianni M, Zanusso G, Balestrino M, Roccatagliata L (2018) Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease. Eur J Neurol 25:E127\u2013EE28","journal-title":"Eur J Neurol"},{"key":"4_CR75","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1315200","volume":"371","author":"CD Orru","year":"2014","unstructured":"Orru CD, Bongianni M, Tonoli G, Ferrari S, Hughson AG, Groveman BR, Fiorini M, Pocchiari M, Monaco S, Caughey B, Zanusso G (2014) A test for Creutzfeldt-Jakob disease using Nasal brushings. N Engl J Med 371:519\u2013529","journal-title":"N Engl J Med"},{"key":"4_CR76","doi-asserted-by":"publisher","first-page":"e02451","DOI":"10.1128\/mBio.02451-14","volume":"6","author":"CD Orr\u00fa","year":"2015","unstructured":"Orr\u00fa CD, Groveman BR, Hughson AG, Zanusso G, Coulthart MB, Caughey B (2015) Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. MBio 6:e02451","journal-title":"MBio"},{"key":"4_CR77","first-page":"4983","volume":"11","author":"CD Orru","year":"2015","unstructured":"Orru CD, Groveman BR, Raymond LD, Hughson AG, Nonno R, Zou WQ, Ghetti B, Gambetti P, Caughey B (2015) Bank Vole Prion protein as an apparently universal substrate for RT-QuIC-based detection and discrimination of Prion strains. PLoS Pathog 11:4983\u20134983","journal-title":"PLoS Pathog"},{"key":"4_CR78","doi-asserted-by":"publisher","first-page":"eaam7785","DOI":"10.1126\/scitranslmed.aam7785","volume":"9","author":"CD Orr\u00fa","year":"2017","unstructured":"Orr\u00fa CD, Yuan J, Appleby BS, Li B, Li Y, Winner D, Wang Z, Zhan YA, Rodgers M, Rarick J, Wyza RE, Joshi T, Wang GX, Cohen ML, Zhang S, Groveman BR, Petersen RB, Ironside JW, Quinones-Mateu ME, Safar JG, Kong Q, Caughey B, Zou WQ (2017) Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease. Sci Transl Med 9:eaam7785","journal-title":"Sci Transl Med"},{"key":"4_CR79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00401-010-0779-6","volume":"121","author":"P Parchi","year":"2011","unstructured":"Parchi P, Strammiello R, Giese A, Kretzschmar H (2011) Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. Acta Neuropathol 121:91\u2013112","journal-title":"Acta Neuropathol"},{"key":"4_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/2013.jamaneurol.79","volume":"69","author":"RW Paterson","year":"2012","unstructured":"Paterson RW, Torres-Chae CC, Kuo AL, Ando T, Nguyen EA, Wong K, Dearmond SJ, Haman A, Garcia P, Johnson DY, Miller BL, Geschwind MD (2012) Differential diagnosis of Jakob-Creutzfeldt disease. Arch Neurol 69:1\u20135","journal-title":"Arch Neurol"},{"key":"4_CR81","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1099\/vir.0.033365-0","volume":"93","author":"AH Peden","year":"2012","unstructured":"Peden AH, McGuire LI, Appleford NE, Mallinson G, Wilham JM, Orru CD, Caughey B, Ironside JW, Knight RS, Will RG, Green AJ, Head MW (2012) Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion. J Gen Virol 93:438\u2013449","journal-title":"J Gen Virol"},{"key":"4_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01652176.2024.2424837","volume":"44","author":"S P\u00e9rez-L\u00e1zaro","year":"2024","unstructured":"P\u00e9rez-L\u00e1zaro S, Barrio T, Bravo SB, Sevilla E, Otero A, Chantada-V\u00e1zquez MDP, Mart\u00edn-Burriel I, Requena JR, Badiola JJ, Bolea R (2024) New preclinical biomarkers for prion diseases in the cerebrospinal fluid proteome revealed by mass spectrometry. Vet Q 44:1\u201315","journal-title":"Vet Q"},{"key":"4_CR83","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1750-3639.1998.tb00171.x","volume":"8","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) The prion diseases. Brain Pathol 8:499\u2013513","journal-title":"Brain Pathol"},{"key":"4_CR84","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","volume":"11","author":"G Puoti","year":"2012","unstructured":"Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P (2012) Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 11:618\u2013628","journal-title":"Lancet Neurol"},{"key":"4_CR85","doi-asserted-by":"publisher","first-page":"31175","DOI":"10.1172\/jci.insight.131175","volume":"4","author":"GJ Raymond","year":"2019","unstructured":"Raymond GJ, Zhao HT, Race B, Raymond LD, Williams K, Swayze EE, Graffam S, Le J, Caron T, Stathopoulos J, O'Keefe R, Lubke LL, Reidenbach AG, Kraus A, Schreiber SL, Mazur C, Cabin DE, Carroll JB, Minikel EV, Kordasiewicz H, Caughey B, Vallabh SM (2019) Antisense oligonucleotides extend survival of prion-infected mice. JCI Insight 4:31175\u201331175","journal-title":"JCI Insight"},{"key":"4_CR86","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","volume":"95","author":"DD Rhoads","year":"2020","unstructured":"Rhoads DD, Wrona A, Foutz A, Blevins J, Glisic K, Person M, Maddox RA, Belay ED, Schonberger LB, Tatsuoka C (2020) Diagnosis of prion diseases by RT-QuIC results in improved surveillance. Neurology 95:e1017\u2013e1e26","journal-title":"Neurology"},{"key":"4_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054915","volume":"8","author":"K Sano","year":"2013","unstructured":"Sano K, Satoh K, Atarashi R, Takashima H, Iwasaki Y, Yoshida M, Sanjo N, Murai H, Mizusawa H, Schmitz M, Zerr I, Kim Y-S, Nishida N (2013) Early detection of abnormal Prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One 8:e54915","journal-title":"PLoS One"},{"key":"4_CR88","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/jnnp.2008.155242","volume":"82","author":"K Satoh","year":"2011","unstructured":"Satoh K, Nakaoke R, Nishiura Y, Tsujino A, Motomura M, Yoshimura T, Sasaki K, Shigematsu K, Shirabe S, Eguchi K (2011) Early detection of sporadic CJD by diffusion-weighted MRI before the onset of symptoms. J Neurol Neurosurg Psychiatry 82:942\u2013943","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4_CR89","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/nprot.2016.120","volume":"11","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Cramm M, Llorens F, Muller-Cramm D, Collins S, Atarashi R, Satoh K, Orru CD, Groveman BR, Zafar S, Schulz-Schaeffer WJ, Caughey B, Zerr I (2016) The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat Protoc 11:2233\u20132242","journal-title":"Nat Protoc"},{"key":"4_CR90","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/brain\/awab350","volume":"145","author":"M Schmitz","year":"2022","unstructured":"Schmitz M, Villar-Pique A, Hermann P, Escaramis G, Calero M, Chen C, Kruse N, Cramm M, Golanska E, Sikorska B, Liberski PP, Pocchiari M, Lange P, Stehmann C, Sarros S, Marti E, Baldeiras I, Santana I, Zakova D, Mitrova E, Dong XP, Collins S, Poleggi A, Ladogana A, Mollenhauer B, Kovacs GG, Geschwind MD, Sanchez-Valle R, Zerr I, Llorens F (2022) Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases. Brain 145:700\u2013712","journal-title":"Brain"},{"key":"4_CR91","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1056\/NEJMc2214647","volume":"388","author":"M Schmitz","year":"2023","unstructured":"Schmitz M, Correia SS, Hermann P, Maass F, Goebel S, Bunck T, Correia A, Lingor P, Fischer A, Zerr I (2023) Detection of Prion protein seeding activity in tear fluids. N Engl J Med 388:1816\u20131817","journal-title":"N Engl J Med"},{"key":"4_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106075","volume":"180","author":"M Senesi","year":"2023","unstructured":"Senesi M, Lewis V, Adlard PA, Finkelstein DI, Kim JH, Collins SJ (2023a) Tailored behavioural tests reveal early and progressive cognitive deficits in M1000 prion disease. Neurobiol Dis 180:106075","journal-title":"Neurobiol Dis"},{"key":"4_CR93","doi-asserted-by":"publisher","first-page":"1072952","DOI":"10.3389\/fneur.2023.1072952","volume":"14","author":"M Senesi","year":"2023","unstructured":"Senesi M, Lewis V, Varghese S, Stehmann C, McGlade A, Doecke JD, Ellett L, Sarros S, Fowler CJ, Masters CL, Li Q-X, Collins SJ (2023b) Diagnostic performance of CSF biomarkers in a well-characterized Australian cohort of sporadic Creutzfeldt-Jakob disease. Front Neurol 14:1072952","journal-title":"Front Neurol"},{"key":"4_CR94","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/jamaneurol.2013.6455","volume":"71","author":"T Skillback","year":"2014","unstructured":"Skillback T, Rosen C, Asztely F, Mattsson N, Blennow K, Zetterberg H (2014) Diagnostic performance of cerebrospinal fluid total Tau and phosphorylated Tau in Creutzfeldt-Jakob disease results from the Swedish Mortality Registry. JAMA Neurol 71:476\u2013483","journal-title":"JAMA Neurol"},{"key":"4_CR95","first-page":"47","volume":"2018","author":"C Stehmann","year":"2023","unstructured":"Stehmann C, Senesi M, Sarros S, McGlade A, Lewis V, Ellett L, Barber D, Simpson M, Klug G, McLean CA, Masters CL, Collins SJ (2023) Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2022. Commun Dis Intell 2018:47","journal-title":"Commun Dis Intell"},{"key":"4_CR96","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1093\/brain\/aws238","volume":"135","author":"K Stoeck","year":"2012","unstructured":"Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, Sanchez-Valle R, Mitrova E, Sklaviadis T, Kulczycki J, Slivarichova D, Saiz A, Calero M, Knight R, Aguzzi A, Laplanche JL, Peoc'h K, Schelzke G, Karch A, van Duijn CM, Zerr I (2012) Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain 135:3051\u20133061","journal-title":"Brain"},{"key":"4_CR97","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1212\/WNL.0000000000003013","volume":"87","author":"K Suzuki","year":"2016","unstructured":"Suzuki K, Kawasaki A, Nagashima T, Hirata K (2016) Diffusion-weighted MRI abnormalities antedate the onset of sporadic Creutzfeldt-Jakob disease. Neurology 87:843\u2013845","journal-title":"Neurology"},{"key":"4_CR98","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jns.2012.04.004","volume":"319","author":"Y Terasawa","year":"2012","unstructured":"Terasawa Y, Fujita K, Izumi Y, Kaji R (2012) Early detection of familial Creutzfeldt-jakob disease on diffusion-weighted imaging before symptom onset. J Neurol Sci 319:130\u2013132","journal-title":"J Neurol Sci"},{"key":"4_CR99","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1182\/blood.2024024649","volume":"144","author":"CM Thomas","year":"2024","unstructured":"Thomas CM, Salamat MKF, Almela F, Cooper JK, Ladhani K, Arnold ME, Bougard D, Andr\u00e9oletti O, Houston EF (2024) Longitudinal detection of prion infection in preclinical sheep blood samples compared using 3 assays. Blood 144:1962\u20131973","journal-title":"Blood"},{"key":"4_CR100","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1038\/s41380-021-01045-w","volume":"26","author":"AGB Thompson","year":"2021","unstructured":"Thompson AGB, Anastasiadis P, Druyeh R, Whitworth I, Nayak A, Nihat A, Mok TH, Rudge P, Wadsworth JDF, Rohrer J, Schott JM, Heslegrave A, Zetterberg H, Collinge J, Jackson GS, Mead S (2021) Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases. Mol Psychiatry 26:5955\u20135966","journal-title":"Mol Psychiatry"},{"key":"4_CR101","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/13554794.2020.1787458","volume":"26","author":"RA Townley","year":"2020","unstructured":"Townley RA, Polsinelli AJ, Fields JA, Machulda MM, Jones DT, Graff-Radford J, Kantarci KM, Lowe VJ, Rademakers RV, Baker MC, Kumar N, Boeve BF (2020) Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion inPRNP: the next generation. Neurocase 26:211\u2013219","journal-title":"Neurocase"},{"key":"4_CR102","doi-asserted-by":"publisher","first-page":"9506","DOI":"10.1212\/WNL.0000000000209506","volume":"103","author":"SM Vallabh","year":"2024","unstructured":"Vallabh SM, Mortberg MA, Allen SW, Kupferschmid AC, Kivisakk P, Hammerschlag BL, Bolling A, Trombetta BA, Devitte-McKee K, Ford AM, Sather LE, Duffy G, Rivera A, Gerber J, McManus AJ, Minikel EV, Arnold SE (2024) Fluid biomarkers in individuals at risk for genetic prion disease up to disease conversion. Neurology 103:9506\u20139506","journal-title":"Neurology"},{"key":"4_CR103","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00415-016-8022-6","volume":"263","author":"F Verde","year":"2016","unstructured":"Verde F, Ticozzi N, Messina S, Calcagno N, Girotti F, Maderna L, Moda F, Scola E, Falini A, Tagliavini F, Silani V (2016) MRI abnormalities found 1 year prior to symptom onset in a case of Creutzfeldt-Jakob disease. J Neurol 263:597\u2013599","journal-title":"J Neurol"},{"key":"4_CR104","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41467-018-08130-9","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang Z, Manca M, Foutz A, Camacho MV, Raymond GJ, Race B, Orru CD, Yuan J, Shen P, Li B, Lang Y, Dang J, Adornato A, Williams K, Maurer NR, Gambetti P, Xu B, Surewicz W, Petersen RB, Dong X, Appleby BS, Caughey B, Cui L, Kong Q, Zou WQ (2019) Early preclinical detection of prions in the skin of prion-infected animals. Nat Commun 10:247","journal-title":"Nat Commun"},{"key":"4_CR105","doi-asserted-by":"publisher","first-page":"e1003990","DOI":"10.1371\/journal.ppat.1003990","volume":"10","author":"JC Watts","year":"2014","unstructured":"Watts JC, Giles K, Patel S, Oehler A, DeArmond SJ, Prusiner SB (2014) Evidence that Bank Vole PrP is a universal acceptor for Prions. PLoS Pathog 10:e1003990","journal-title":"PLoS Pathog"},{"key":"4_CR106","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/brain\/awn202","volume":"131","author":"TEF Webb","year":"2008","unstructured":"Webb TEF, Poulter M, Beck J, Uphill J, Adamson G, Campbell T, Linehan J, Powell C, Brandner S, Pal S, Siddique D, Wadsworth JD, Joiner S, Alner K, Petersen C, Hampson S, Rhymes C, Treacy C, Storey E, Geschwind MD, Nemeth AH, Wroe S, Collinge J, Mead S (2008) Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 131:2632\u20132646","journal-title":"Brain"},{"key":"4_CR107","volume-title":"Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies : report of a WHO consultation, Geneva, Switzerland, 9\u201311 February 1998","author":"WHO","year":"1998","unstructured":"WHO (1998) Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies : report of a WHO consultation, Geneva, Switzerland, 9\u201311 February 1998. World Health Organization, Geneva"},{"key":"4_CR108","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.clinph.2005.12.007","volume":"117","author":"HG Wieser","year":"2006","unstructured":"Wieser HG, Schindler K, Zumsteg D (2006) EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol 117:935\u2013951","journal-title":"Clin Neurophysiol"},{"key":"4_CR109","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","volume":"347","author":"RG Will","year":"1996","unstructured":"Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921\u2013925","journal-title":"Lancet"},{"key":"4_CR110","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jamaneurol.2024.4447","volume":"82","author":"R Wurm","year":"2025","unstructured":"Wurm R, Klotz S, Erber A, Gruber F, Leitner S, Reichardt B, St\u00f6gmann E, Schernhammer E, Gelpi E, Cetin H (2025) Mood alterations in the prodromal phase of Sporadic Creutzfeldt-Jakob disease. JAMA Neurol 82:185\u2013192","journal-title":"JAMA Neurol"},{"key":"4_CR111","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s12264-019-00354-z","volume":"35","author":"K Xiao","year":"2019","unstructured":"Xiao K, Shi Q, Zhou W, Zhang B-Y, Wang Y, Chen C, Ma Y, Gao C, Dong X-P (2019) T188K-familial Creutzfeldt\u2013Jacob disease, predominant among Chinese, has a reactive pattern in CSF RT-QuIC different from D178N-Fatal Familial Insomnia and E200K-Familial CJD. Neurosci Bull 35:519\u2013521","journal-title":"Neurosci Bull"},{"key":"4_CR112","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1212\/WNL.52.2.260","volume":"52","author":"M Yamada","year":"1999","unstructured":"Yamada M, Tomimitsu H, Yokota T, Tomi H, Sunohara N, Mukoyama M, Itoh Y, Suematsu N, Otomo E, Okeda R, Matsushita M, Mizusawa H (1999) Involvement of the spinal posterior horn in Gerstmann-Str\u00e4ussler- Scheinker disease (PrP P102L). Neurology 52:260\u2013265","journal-title":"Neurology"},{"key":"4_CR113","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1212\/WNL.0000000000201221","volume":"99","author":"M Yasuda","year":"2022","unstructured":"Yasuda M, Sugiyama A, Hokkoku H, Suichi T, Ito K, Satoh K, Kitamoto T, Kuwabara S (2022) Propagation of diffusion-weighted MRI abnormalities in the preclinical stage of Sporadic Creutzfeldt-Jakob disease. Neurology 99:699\u2013702","journal-title":"Neurology"},{"key":"4_CR114","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ana.24757","volume":"80","author":"G Zanusso","year":"2016","unstructured":"Zanusso G, Camporese G, Ferrari S, Santelli L, Bongianni M, Fiorini M, Monaco S, Manara R, Cagnin A (2016) Long-term preclinical magnetic resonance imaging alterations in Sporadic Creutzfeldt-Jakob disease. Ann Neurol 80:629\u2013632","journal-title":"Ann Neurol"},{"key":"4_CR115","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt Jakob disease. Brain 132:2659","journal-title":"Brain"}],"container-title":["Subcellular Biochemistry","Biomarkers and Therapeutical Targets for Prion Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-97055-9_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:02:52Z","timestamp":1773831772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-97055-9_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031970542","9783031970559"],"references-count":115,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-97055-9_4","relation":{},"ISSN":["0306-0225","2542-8810"],"issn-type":[{"value":"0306-0225","type":"print"},{"value":"2542-8810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"1 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}